• English
    • svenska
  • English 
    • English
    • svenska
  • Login
View Item 
  •   Home
  • Sahlgrenska Academy / Sahlgrenska akademin
  • Institute of Clinical Sciences / Institutionen för kliniska vetenskaper
  • Doctoral Theses / Doktorsavhandlingar Institutionen för kliniska vetenskaper
  • View Item
  •   Home
  • Sahlgrenska Academy / Sahlgrenska akademin
  • Institute of Clinical Sciences / Institutionen för kliniska vetenskaper
  • Doctoral Theses / Doktorsavhandlingar Institutionen för kliniska vetenskaper
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Breast Hypertrophy and outcome of Breast Reduction Surgery

Abstract
Aim: The overall aim of this thesis was to improve our knowledge of breast hypertrophy in women, its associated problems, and the outcome of breast reduction. Patients and methods: I. Five hundred and twelve woman were studied retrospectively for prevalence of and risk factors for complications. II. The study included 325 women, either randomized to prophylactic antibiotics or not. III. The Breast Evaluation Questionnaire (BEQ) for women with breast hypertrophy and breast reduction was validated. Two hundred and twentyfive women who had had breast reduction surgery and 216 controls were included. IV. Three hundred and forty-eight women were evaluated for gain in health-related quality of life (HRQL) after breast reduction surgery in this prospective, longitudinal paired study.Results: I. A long suprasternal notch to nipple distance increased the risk of infection and necrosis of the nipple. High BMI increased the risk of wound infection. A larger weight of resection increased the risk of delayed wound healing and fat necrosis. Smokers have twice the risk of getting a postoperative infection and diabetics are at higher risk of nipple necrosis. II. The incidence of postoperative infections was not significantly different between the groups. III. The modified BEQ is valid and shows good reliability. IV. Breast hypertrophy is associated with low HRQL, and breast reduction surgery increases HRQL. Conclusions: I. Sternal notch to nipple distance, BMI, resection weight, diabetes mellitus, and smoking are independent risk factors for complications after breast reduction surgery. II. One prophylactic dose of 2 g intravenous Cloxacillin or 600 mg Clindamycin did not reduce the incidence of postoperative infections. III. The BEQ has proven to be valid and to have good stability after being modified (mBEQ), when used before and after breast reduction surgery. IV. Women with breast hypertrophy have reduced quality of life and the HRQL is strongly increased or normalized after breast reduction surgery when SF- 36, mBEQ, BRSQ, and BREAST-Q are analyzed. Those with a higher body mass index, a longer sternal notch to nipple distance, a larger preoperative breast volume, or large volume of breast resection enjoy gains in healthrelated quality of life that are similar to, although probably not greater than, other women.
Parts of work
I) Lewin R, Göransson M, Elander A, Thorarinsson A, Lundberg J, Lidén M. Risk factors for complications after breast reduction surgery. J Plast Surg Hand Surg. 2014;48:10-14 ::PMID::23627557
 
II) Lewin R, Elander A, Thorarinsson A, Kölby L, Sahlin P-E, Lundberg J, Panczel A, Lidén M. A Randomized Prospective Study of Prophylactic Cloxacillin in Breast Reduction Surgery. Annals of Plastic Surgery 2015; Jan;74(1):17-21 ::PMID::25305230
 
III) Lewin R, Elander A, Lundberg J, Thorarinsson A, Claudelin M, Bladh H, Lidén M. Validation of the Breast Evaluation Questionnaire for women subjected to breast reduction surgery. Submitted 2016
 
IV) Lewin R, Lidén M, Selvaggi G, Lundberg J, Thorarinsson A, Elander A. Prospective evaluation of health after breast-reduction surgery using BREAST-Q, SF-36, BRSQ and modified BEQ. Manuscript
 
Degree
Doctor of Philosophy (Medicine)
University
University of Gothenburg. Sahlgrenska Academy
Institution
Institute of Clincial Sciences. Department of Plastic Surgery
Disputation
Torsdagen den 3 mars, kl 13.00, Aulan Sahlgrenska, Blå stråket 5, Göteborg
Date of defence
2016-03-03
E-mail
richard.lewin@vgregion.se
URI
http://hdl.handle.net/2077/41241
Collections
  • Doctoral Theses / Doktorsavhandlingar Institutionen för kliniska vetenskaper
  • Doctoral Theses from Sahlgrenska Academy
  • Doctoral Theses from University of Gothenburg / Doktorsavhandlingar från Göteborgs universitet
View/Open
Thesis frame (14.03Mb)
Cover (2.615Mb)
Abstract (220.7Kb)
Date
2016-02-09
Author
Lewin, Richard
Keywords
Breast
Reduction
Mammaplasty
HRQL
Complications
Validation
Reliability
Breast Hypertrophy
Questionnaire
Publication type
Doctoral thesis
ISBN
978-91-628-9706-2 (PDF)
978-91-628-9706-2 (PRINT)
Language
eng
Metadata
Show full item record

DSpace software copyright © 2002-2016  DuraSpace
Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

DSpace software copyright © 2002-2016  DuraSpace
Contact Us | Send Feedback
Theme by 
Atmire NV